Government ‘closely’ reviewing new monoclonal antibody drugs after EMA approval
The Agency has granted authorisation to two treatments which significantly reduced the mortality rate of Covid-19 among patients studied
Ireland could soon have another tool in its fight against Covid-19, after the government confirmed it was reviewing a new type of treatment which has just received authorisation from Europe’s medical watchdog.
A pair of monoclonal antibody medicines – a type of treatment which has been shown to lessen the severity of Covid symptoms – were granted approval by the European Medicines Agency (EMA) last Thursday.
A treatment developed by Regeneron, the US...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Holohan to brief party leaders as Omicron variant ‘likely’ in Ireland
The coalition leaders will meet with the chief medical officer later today to discuss the variant and the wider Covid-19 situation
Cillian De Gascun: ‘It won’t be a traditional Irish Christmas. We just can’t afford to do that again’
Combination of people going to restaurants and pubs before Christmas followed by intergenerational mixing over the holidays would be a disaster, according to key Nphet member
De Gascun: arrival of Omicron in Ireland ‘only a matter of time’
Nphet member says major surveillance drive is underway to identify any cases of new Covid-19 variant
The spectre of Omicron: ‘It’s like something Dr Evil would construct on an island lair’
The emergence of the new coronavirus variant has sparked alarm among governments and volatility on the markets, with travel from southern Africa being restricted and blue-chip stocks falling sharply